Skip to main navigation
Skip to search
Skip to main content
WashU Medicine Research Profiles Home
Help & FAQ
Home
Profiles
Departments, Divisions and Centers
Research output
Search by expertise, name or affiliation
Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia
Jayastu Senapati
,
Samuel Urrutia
, Sanam Loghavi
, Nicholas J. Short
, Ghayas C. Issa
, Abhishek Maiti
, Hussein A. Abbas
, Naval G. Daver
, Naveen Pemmaraju
, Sherry Pierce
, Kelly S. Chien
, Koji Sasaki
, Tapan M. Kadia
, Danielle E. Hammond
, Gautam Borthakur
, Keyur Patel
, Farhad Ravandi
, Hagop M. Kantarjian
, Guillermo Garcia-Manero
, Courtney D. DiNardo
Siteman Cancer Center
Section of Hematological Malignancies
Research output
:
Contribution to journal
›
Article
›
peer-review
55
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Venetoclax abrogates the prognostic impact of splicing factor gene mutations in newly diagnosed acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Newly Diagnosed
100%
Acute Myeloid Leukemia
100%
Prognostic Impact
100%
Splicing Factor Gene mutations
100%
Venetoclax
100%
Overall Survival
60%
Intensive Care Medicine
60%
Relapse-free Survival
60%
SRSF2
40%
Young Patients
20%
Multivariate Analysis
20%
Risk Stratification
20%
Splicing Factor mutations
20%
Prognostic Model
20%
Hazard of Relapse
20%
SF3B1
20%
U2AF1
20%
Leukemia Risk
20%
Adverse Risk
20%
ZRSR2
20%
European LeukemiaNet
20%
Splicing Factor Genes
20%
Leukemia Data
20%
Medicine and Dentistry
Gene Mutation
100%
Acute Myeloid Leukemia
100%
Venetoclax
100%
Intensive Care
60%
Overall Survival
60%
Recurrence Free Survival
60%
Arm
40%
Risk Stratification
20%
Prognostic Model
20%
Multivariate Analysis
20%